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The causal interrogation of neuronal networks involved in specific behaviors requires
the spatially and temporally controlled modulation of neuronal activity. For long-term
manipulation of neuronal activity, chemogenetic tools provide a reasonable alternative
to short-term optogenetic approaches. Here we show that virus mediated gene transfer
of the ivermectin (IVM) activated glycine receptor mutant GlyR AGα1 can be used for
the selective and reversible silencing of specific neuronal networks in mice. In the
striatum, dorsal hippocampus, and olfactory bulb, GlyR AGα1 promoted IVM dependent
effects in representative behavioral assays. Moreover, GlyR AGα1 mediated silencing had
a strong and reversible impact on neuronal ensemble activity and c-Fos activation in
the olfactory bulb. Together our results demonstrate that long-term, reversible and re-
inducible neuronal silencing via GlyR AGα1 is a promising tool for the interrogation of
network mechanisms underlying the control of behavior and memory formation.
Keywords: glycine receptor, ivermectin, neuronal silencing, odor discrimination, rAAV
INTRODUCTION
To elucidate the mechanisms underlying cognitive processes and behavior, we need tools to
reversibly manipulate neuronal activity. Classically, lesion studies have allowed researchers to study
the function of certain brain regions through chronic ablation of brain tissue; however, the latter
is irreversible and lacks the cellular specificity required for the analysis of neuronal networks.
Therefore, novel molecular tools have been developed which permit the reversible silencing or
activation of specific neurons in vitro and in vivo. In particular the field of optogenetics has
expanded rapidly, and neuronal excitability can now be controlled on millisecond time scales
by shining light on cells expressing either excitatory or inhibitory light-gated ion channels or
pumps (Boyden et al., 2005; Zhang et al., 2007; Chow et al., 2010; Govorunova et al., 2015).
However, long-term silencing and the manipulation of spatially distributed neuronal ensembles
are very difficult to achieve with optogenetics (Ferenczi and Deisseroth, 2012; Raimondo et al.,
2012). Hence, chemogenetic silencing receptors have been created which can negatively modulate
neuronal firing rates through Gi/o coupled pathways after activation through pharmacologically
inert drugs (Armbruster et al., 2007; Vardy et al., 2015).
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Here, we tested a silencing approach, which relies on a
chloride channel that is gated by the common anthelminthic
drug ivermectin (IVM) (Drameh et al., 2002; Wolstenholme
and Rogers, 2005) for its suitability to interrogate neuronal
network function in vivo. As described by Lynagh and Lynch,
the combination of two mutations (F207A and A288G) in the
α1 subunit of the human glycine receptor (GlyRα1
AG) strongly
increases the sensitivity to nanomolar IVM concentrations of
homomeric GlyRα1
AG and heteromeric GlyRα1
AGβ receptors
with a concomitant decrease in glycine efficacy (Lynagh and
Lynch, 2010). This change in ligand specificity provides the basis
for IVM mediated silencing of neurons expressing GlyRα1
AG.
A similar approach based upon an IVM gated chloride channel
from C. elegans (GluClαβ) has been successfully used to silence
neurons in vivo (Lerchner et al., 2007), but relied on co-infection
with two viruses, each carrying a subunit of the receptor, to be
functional.
To examine whether viral GlyRα1
AG delivery can provide
robust and reversible silencing of neurons in rodents, we
expressed GlyRα1
AG as a T2A fusion (Tang et al., 2009) with
a fluorescent reporter via recombinant adeno-associated virus
(rAAV) vectors under the control of the human synapsin
promotor (Kügler et al., 2003). After stereotactic virus injection,
rAAV transduced GlyRα1
AG was efficiently expressed in neurons
of the striatum, the hippocampus, and the olfactory bulb
(OB) of mice. In these GlyRα1
AG expressing mouse cohorts,
single intraperitoneal (i.p.) IVM injections evoked phenotypes
in representative behavioral assays, which were fully reversible
within 1 week. In the OB, we could demonstrate successful
silencing of neurons at both molecular and network levels
through the lack of odor induced c-Fos expression in neurons
that expressed IVM sensitive GlyRα1
AG, and by a reversible
shift in the frequency of gamma oscillations. Our results provide
strong evidence that IVM dependent long-term reversible
silencing of rAAV transduced neuronal networks is a promising
tool for the interrogation of network function that can be applied
to various model organisms.
MATERIALS AND METHODS
Legal Aspects and Animal Housing
All experiments were registered as biological security “level
S1” at the governmental council in Tübingen, Germany
(Az: 57-2/8817.40-020/MPIMF.HD.00). Animal handling and
experimental procedures were performed according to the
animal welfare guidelines of the Max Planck Society, and under
the licenses 35-9185.81/G-71/10 and 35-9185.81/G-171/10 of
the governmental council in Karlsruhe, Germany. Efforts were
made to minimize numbers of animals used. Data from about
60 5–6 weeks old C57BL/6N male mice and the embryos of
three pregnant female rats (Sprague-Dawley, Charles River) are
presented in this study.
Behavioral Tests
C57BL/6N mice were housed on a 12-h light:12-h dark cycle
(lights on at 08:00) in groups of four to six in plastic cages, with
wood shavings bedding and a cardboard tube to provide some
environmental enrichment. Behavioral testing was performed
during the light phase. Food and water were provided ad libitum,
except during training on appetite-motivated tasks (T-maze,
olfactory discrimination task). For these, mice were fed a small
amount of food pellets each day, such that their body weight was
∼90% of that under free feeding conditions, but never below
80%. Before the start of a behavioral experiment, mice were
handled by picking them up from their home cage and allowed
to explore the experimenter’s lab coat. Each mouse was handled
in 5-min sessions for a minimum of 3 days before starting the
experiments.
Antibodies Used in Immunofluorescence
(IF) and Immunoblots (IB)
Primary: mα-GFP (Clontech), 1:2500–1:2000 (IB); chkα-
GFP (Abcam), 1:5000 (IF); mα-NeuN (Chemicon) 1:1000
(IF); rα-2A peptide (Millipore), 1:1000 (IB); α-GAPDH
(Abcam), 1:2000 (IB); rα-GFAP (Abcam), 1:700 (IF); mα-
beta actin (Sigma), 1:7000 (IB); mα-4A (alpha subunits
glycine receptor, Connex GmbH), 1:600 (IB), 1: 300–
1:200 (IF); mα-2B (alpha 1 subunits glycine receptor
(Becker et al., 1993), Connex GmbH), 1:600 (IB); mα-
Beta3Tubulin (R&D Systems), 1:200 (IF); rα-cfos (Calbiochem),
1:800 (IF). Secondary: FITC-labeled α-chicken (Jackson
Immuno Research), 1:700 (IF); Cy3-labeled α-mouse
(Jackson Immuno Research), 1:700 (IF); Cy5-labeled α-rabbit
(Jackson Immuno Research), 1:900–1:700 (IF); IRDye R©700DX
Conjugated (Rockland Immunochemicals), 1:7000 (IB);
IRDye R©800 Conjugated (Rockland Immunochemicals),
1:7000 (IB).
Drug Injections
Ivermectin (IVM, Ivomec Merial), 1.5–2.5mg/kg, and
amphetamine (AMP, Sigma Aldrich A5880), 3.5mg/kg, were
diluted in phosphate-buffered saline (PBS) for i.p. injections.
The injection volume was 300µl. Diazepam (Sigma Aldrich) was
dissolved in a 10% (2-hydroxypropyl)-β-cyclodextrin solution
(Sigma Aldrich) to a stock concentration of 0.4mg/ml. 4mg/kg
diazepam were injected i.p.. The injection volume was 500µl.
Control mice received PBS injections of the corresponding
volume.
Generation and Production of rAAV Vectors
For the generation of plasmid pAAV-Syn-GlyRα1
AG-2A-Venus,
the mutations F207A and A288G were introduced by primer
directed mutagenesis in a GlyRα1 cDNA template. Next the
GlyRα1
AG coding region or the non-mutated GlyRα1 was used
to replace the ChR2A-NpHR open reading frame in pAAV-
Syn-ChR2A-NpHR2A-Venus (Tang et al., 2009). For pAAV-syn-
Venus, see (Pilpel et al., 2009). Viral rAAV 1/2 serotype vectors
were generated in HEK293 cells as described elsewhere (McClure
et al., 2011). Cells were harvested 48–60 h after transfection. Cell
lysate and supernatant were pooled, and rAAVs were purified
by affinity chromatography (Smith et al., 2009). Genomic titers
of 1011–1012 rAAV genomes/ml virus stock were determined by
Taqman RT-PCR (Applied Biosystem). Virus aliquots were stored
at−80◦C.
Frontiers in Molecular Neuroscience | www.frontiersin.org 2 August 2016 | Volume 9 | Article 75
Obenhaus et al. Causal Interrogation of Neuronal Networks
Virus Expression in Hippocampal Primary
Neurons
Dissociated hippocampal primary neurons from embryonic
day 18 Sprague-Dawley rats (Charles River Laboratories) were
prepared and cultured as described elsewhere (Berkel et al., 2012).
About 104 cells were infected with 108–109 viral particles 3
days after plating (DIV 3). Virus expression was monitored by
fluorescence microscopy 7–21 days after infection.
Immunofluorescence Analysis of Primary
Neurons
For immunofluorescence analysis of primary hippocampal
neurons, the medium in each well was sucked away, and neurons
were washed briefly with PBS at 36◦C, fixed with warm 4%
paraformaldehyde (PFA, 37◦C) in PBS for 8min, and washed
with PBS twice. Cells were permeabilized with 0.25% Triton X-
100 in PBS for 5min, washed in PBS and blocked with 3% bovine
serum albumin (BSA) and 10% normal goat serum (NGS) in
PBS for 30min prior to incubation with primary antibodies in
3% BSA for 1 h. Afterwards the cells were washed four times for
5min in 3% BSA and stained with secondary antibodies in 3%
BSA for 45min. Then they were washed again in PBS for four
times 5min. For counterstaining 4′,6-diamidino-2-phenylindole
(DAPI, Sigma-Aldrich) was added to the second washing step
(1:5000). Slices were mounted on glass slides using 80% glycerol
in PBS. Cover slips were fixed in place with nail polisher.
Stereotactic Injections
Stereotactic injections on 5–6 week old C57BL/6N mice were
performed as described elsewhere (Cetin et al., 2006). The
virus was injected via glass pipettes (tip diameter 10–20µm).
Hippocampus injection coordinates (from Bregma): −2.1mm
anteroposterior (ap), for CA1 and DG: ±1mm lateral (lat)
and 1/1.7mm depth, for CA3: ±2.1mm lat and 1.6mm depth
(Volume: 200–300 nl per site). Striatum: −1mm ap, 2.2mm
lat, 3.3/3.8mm depth (Volume: 400–450 nl). Olfactory bulb:
+4mm ap, 0.5mm lat, 1.3/1mm depth (Volume: 500 nl). Mice
were given at least 2 weeks to recover from the surgery before
behavioral testing was started.
Electrophysiology in Acute Hippocampal
Slices
Mice were injected unilaterally with rAAV-syn-GlyRα1
AG-2A-
Venus or rAAV-Syn-Venus (stereotactic injection coordinates:
CA3: −2.1mm ap., ±2.1mm lat., and 1.6mm depth; Volume:
300–350 nl per site). Transverse hippocampal slices (300µm
thick) were prepared 10–14 days after virus injection. The slicing
chamber contained an oxygenated ice-cold solution (modified
from Dugué et al., 2005), composed of (in mM): K-gluconate,
140; N-(2-hydroxyethyl) piperazine-N′-ethanesulfonic acid
(HEPES), 10; Na-gluconate, 15; ethylene glycol-bis (2-
aminoethyl)-N,N,N′,N′-tetraacetic acid (EGTA), 0.2; and
NaCl, 4 (pH 7.2). Slices were incubated for 30min at 35◦C
before being stored at room temperature (RT) in artificial CSF
(ACSF) containing (in mM): NaCl, 125; NaHCO3, 25; KCl,
2.5; NaH2PO4, 1.25; MgCl2, 1; CaCl2, 2; and D-glucose, 25;
bubbled with 95%O2 and 5%CO2. During experiments, slices
were continuously perfused with ACSF. Patch electrodes were
pulled from hard borosilicate capillary glass (Sutter Instruments
flaming/brown micropipette puller). Electrodes for the voltage
clamp experiment were filled with a high chloride solution
which consisted of (in mM) Cs-gluconate, 105; CsCl, 30; HEPES,
10; MgATP, 4; MgGTP, 0.3; phosphocreatine, 10 (pH 7.3 with
CsOH). The low chloride solution for current clamp experiments
consisted of (in mM) K-gluconate, 130; HEPES, 10; KCl 4;
MgATP, 4; MgGTP, 0.3; phosphocreatine, 10 (pH 7.3 with
KOH). For registration of spiking activity in the cell-attached
mode, electrodes were filled with ACSF. CA3 pyramidal cells
were identified visually using IR-video microscopy. Whole-cell
recordings from these neurons were taken at 32◦C using a HEKA
EPC-7 amplifier (List Elektronik) with a sampling rate of 100µs
and filtered at 3 kHz.
Immunostaining of Fixed Brain Slices
Mice were transcardially perfused with PBS followed by 4%
Paraformaldehyde (PFA) in PBS. Brains were post-fixed for 12 h
at 4◦C. Free-floating sections (70µm) were cut using a vibratome
(Leica). For cryostat cutting (c-Fos staining protocol), brains
were immersed in 20% sucrose in PBS overnight followed by
30% sucrose in PBS overnight. Afterwards, brains were frozen
in a small glass beaker filled with isopentane embedded in dry
ice. After 2min in isopentane, frozen brains were stored at
−80◦C. Before sectioning, the frozen brains were transferred
for 3–4 h to −20◦C and then cut in 50µm slices on a cryostat
(Mikrotom Bright Kryostat Modell OTF, Hater instruments).
All sections were stained free-floating. Vibratome and cryostat
slices were incubated for 1 h at room temperature (RT) in
blocking buffer (2% gelatine, 2% BSA, 0.1% Triton X-100 in PBS).
Primary antibodies diluted in blocking solution were added for
an over-night incubation at RT. After washing with a 1:3 dilution
of blocking buffer, slices were transferred to fresh blocking
buffer containing fluorophore-conjugated secondary antibodies
for 1.5 h at RT. In some cases DAPI (1:5000) was mixed into
the final washing steps. After a final wash with PBS, slices were
mounted on glass slides using 80% glycerol in PBS. Cover slips
were fixed in place with nail polisher.
Image Acquisition
Wide-field fluorescence images were acquired with a Zeiss
Axioimager.M1 (Carl Zeiss). Confocal images were acquired at
a resolution of 1024 × 1024 pixels with a Leica SP2 (Leica)
microscope equipped with 10× to 63× (glycerol immersion)
objectives, an UV laser (352 nm), an Argon laser (450–530 nm),
and two HeliumNeon lasers (543 nm). Acquired confocal images
were loaded into ImageJ (Rasband, W.S., ImageJ, U. S. National
Institutes of Health, Bethesda, Maryland, USA, http://imagej.nih.
gov/ij/, 1997–2015), and a maximum intensity projection of 4–6
adjacent slices was calculated. c-Fos immunofluorescence in the
OB: A software controlled x-y stage controller of the Leica SP2
confocal laser scanning microscope was used to scan the whole
brain slice, and for every slice at least 4 depths (z) were imaged.
After acquisition, the images were stitched together using custom
Matlab (Mathworks) routines. The stitched image, which had
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the most homogenous αNeuN signal throughout, was chosen for
further analysis. Six to thirteen 150×150µm square regions were
counted per slice (one slice per mouse).
Expression Analysis
For the analysis of virus expression patterns, wide-field
fluorescence images of αGFP (Venus) stained slices of matching
anterior-posterior coordinates were first aligned to each other
and to schemata taken from a mouse brain atlas (The Mouse
Brain in Stereotaxic Coordinates, George Paxinos and Keith
B. J. Franklin, Academic Press). Aligned images were then
loaded into ImageJ, and the same gamma correction was
applied to all images to decrease background fluorescence and
enhance signal visibility. An average intensity projection was
then calculated, and the contrast was automatically enhanced
(ImageJ; Enhance Contrast: Saturated pixels: 1%). A perceptually
uniform sequential colormap was then applied for pseudo-
coloring (https://github.com/BIDS/colormap, option D).
Immunoblot Analysis
Primary hippocampal cultures (14 days after infection) were
harvested with lysis buffer (80µl/well; 10mM Tris pH 7.4,
150mMNaCl, 2mMEDTA, 0.5%NP40, 1%TX-100). For sample
extraction from brain tissue, mice were killed and decapitated
and their brains dissected on ice. A sub region of the striatum
that was targeted by the stereotactic injection was extracted
and homogenized with 600µl ice-cold Buffer (0.32M sucrose,
2mM EDTA, 5mM HEPES pH 7.4). All preparations were
supplemented with a protease inhibitor cocktail (CompleteTM;
Roche). Protein concentrations were measured using the
Bradford reagent (Sigma Aldrich). Cell lysates were separated
via SDS-polyacrylamide gel electrophoresis (10% separating and
4% stacking gels) and transferred to nitrocellulose membranes
in an electrophoresis chamber over night. The membranes were
blocked with 8% non-fat dry milk in PBS with 0.05% Tween R© 20
(PBS-T) for 1.5 h at room temperature (RT) and were incubated
with primary antibodies overnight at 4◦C. On the next day the
membranes were washed three times with PBS-T for 20min and
then treated with the secondary antibodies in PBS-T for 1.5 h at
RT. After three final washing steps with PBS-T for 20min the
membranes were analyzed on a FLA9000 fluorescence scanner
(GE Healthcare, Life Sciences).
Rotational Bias Testing
Mice were placed in a round metal kitchen bowl (30 cm
diameter) spray painted in white. Videos were recorded from
top for 45min and analyzed oﬄine (Webcam, Logitech, 640 ×
480 pixels). All videos were analyzed using custom Matlab
(Mathworks) routines. Briefly, every analyzed frame of the
video (30 fps original video acquisition, actual analysis rate 5
fps) was thresholded, and a series of morphological operations
was applied to confine the boundaries of the extracted pixel
region to the actual mouse body. The 3-point extraction of the
mouse body was achieved by initializing a k-means clustering
algorithm (k = 3) of the extracted mouse body pixel
region with a slightly larger region that included the mouse
body and tail. This permitted the subsequent extraction of three
center points (front part center, center of the whole region,
back part center), and thereby the extraction of a rotation
angle. The extraction was robust over a wide range of imaging
conditions, as controlled manually in a subset of the analyzed
videos (see also Supplementary Movie 1). All recorded rotation
angles were saved, and differences between rotation angles of
subsequent frames were filtered in between 4 and 120◦. Both
boundaries were set empirically after manual evaluation of the
analysis process had shown that angles below 4◦ represented
mostly noise, and that angles above 120◦ were not occurring
naturally, but represented errors in which the head-tail direction
was accidentally reversed. This way also baseline crossings (0◦)
were filtered out which facilitated the analysis. Rotational bias
was calculated as relative amount of left over all turns. The
difference to baseline (1 Rotation) is given as modulus|(bias after
IVM-baseline bias)|.
Rotarod
Motor-coordination of mice was analyzed on the Rotarod
treadmill (Ugo Basile). The Rotarod consists of a rotating drum
(30× 3 cm) suitably machined to provide grip. Six flanges divide
the drum in five 5.7 cmwide lanes, enabling 5mice to be analyzed
simultaneously. The mice were put on the rotating drum at a
rotation speed of 4 rpm. For each trial, the speed of rotation
increased from 4 to 40 rpm within 8min. The time to fall off the
drum (latency) was recorded for each mouse.
Open Field and Novel Object Exploration
Mice were allowed to explore an open field (50 × 50 × 30 cm)
in a brightly lit environment. After 10min, an object (children
toy) was inserted in the center of the open field (novel object
exploration phase), and mice were allowed to explore object and
open field for another 5min. The mouse path was digitized with
a tracing software (TSE Systems GmbH) and stored in a text file,
which allowed to extract the percentage of time spent in different
regions of the open field and the activity (total path length) for
each mouse.
T-Maze
The rewarded version of the T-maze was performed with fasted
mice as described (Deacon and Rawlins, 2006). In brief: For
habituation, each animal was placed on the start arm of the T-
Maze, with embeddingmaterial of the home cage scattered on the
maze. After 30 s, the block of the start arm was removed, and the
mice were given 3min to find and eat the two food pellets (TSE
Dustless Precision Pellets, TSE Systems GmbH) in the two goal
arms. Then the mice were put back into their home cages. The
actual T-Maze test (rewarded non-matching to sample) always
started with placing the mouse on the start arm. In the forced
sample trial, the entry to one of the goal arms was randomly
blocked. The mouse was allowed to explore the maze and to eat
the food pellet deposited in the open arm. For the subsequent
free choice trial, the mouse was placed back on the start arm,
and the block to the second goal arm was removed. If the animal
entered the arm that had been previously blocked in the forced
sample trial, this was counted as a correct decision. However,
if the animal re-entered the previously unblocked arm, this was
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counted as wrong decision. The minimum inter-trial interval for
each mouse was about 45min. On each test day, 8 trials per
mouse were analyzed. During the course of this experiment, one
virus uninjected control mouse was excluded from final analysis,
since it showed erratic behavior and dropped to 25% performance
on the third test day.
Pellet Seeking Task
For the pellet seeking task, the mouse was transferred to a novel
cage in which a food pellet (TSE Dustless Precision Pellets, TSE
Systems GmbH) was hidden under the wood shavings. The time
to find the pellet in the cage was measured. Unsuccessful trials
were terminated after 10min. Search times were determined in
two subsequent trials; tests were performed twice for eachmouse:
prior to and 1.5 days after i.p. injection of 2.5mg/kg IVM.
Olfactory Discrimination Task
The olfactory discrimination procedure was adapted from
Mihalick et al. (2000). Fastedmice (80–90% original body weight)
were tested in their home cage, which was placed under a fume
hood during all tests. The home cage was split into an empty
home compartment and a test compartment by a plastic wall with
a door at its center. The rewarded test compartment contained a
removable plastic rig, which held two sand-filled lids in place. In
the training phase before the actual discrimination task (4 days, 4
trials permouse per day), mice were presented with only one sand
filled, unscented lid per trial that was randomly placed on the left
or right side on subsequent trials. In the first 2 days, mice had
to discover 3 food pellets (one uncovered on top of one lid, two
other buried in the sand of the lid), and consume them within
15min. Over the next 2 days, only one pellet was hidden in the
sand filled lid, andmice had 15min to find the reward. During the
training, mice were also getting accustomed to sand filled lids that
were placed in their home cage overnight. In the second phase,
the actual discrimination training, mice learned to associate an
odor, either 2-phenylethanol or vanillin (both Sigma Aldrich) to
the location of a food pellet. 2-phenylethanol and vanillin were
chosen since it is known that they are pure odors and therefore
processed exclusively by the main olfactory bulb (Doty et al.,
1978; Frasnelli et al., 2010). Care was taken that the same position
was not chosen more than 3 times on consecutive trials. Odor
dilutions (2% in water) were freshly prepared on every day. At
the beginning of every trial the sand was completely renewed,
a food pellet was put in each of the lids, and 100µl of diluted
odor solution was distributed on top of the sand. Moreover,
each mouse had its own set of lids that was not used for testing
or training other mice. A rewarded/unrewarded odor pair was
randomly assigned to each mouse. The position of each scented
lid was randomized for each trial. In each trial (8 per day, 5min
maximum, see also Supplementary Movie 2), the mouse was first
placed in the home compartment, and the rig with one rewarded
and one non-rewarded odor lid was put in the test compartment.
After 20 s, the home compartment door was opened and the
mouse could enter the test compartment. Searching in the sand
with the right odor was rewarded with a food pellet. The time
was registered until digging began in one lid (Supplementary
Figure 7, “Time to decision in discrimination task”). If mice
started to dig in the lid with the non-rewarded odor, the trial was
ended unrewarded with the retraction of the entire rig. Inter-trial
intervals were at least 30min. If mice performed at or above a
threshold criterion of 7 out of 8 correct trials per day on at least
2 consecutive days, they were i.p. injected with 2.5mg/kg IVM
and were tested again after 0.5 and 1, 5 days. Then testing was
interrupted for the next 7 days, and mice were re-tested on days
8 and 9.
c-Fos Induction Protocol
Unilaterally injectedmice were randomly assigned to two groups,
of which one received IVM (2.5mg/kg) i.p., while the other was
injected with PBS i.p. only. Twenty hours after the i.p. injections,
mice were stimulated intermittently with a mixture of odors and
clean air under a fume hood (Inaki et al., 2002). For this, mice
were transferred to the test room 3 h prior to the odor induction
protocol. Each mouse was placed subsequently into two 2 l glass
beakers for 5min. First in a covered beaker that contained filter
paper scented with 2-phenylethanol, vanillin, and wood shavings
from the cages of other mice and then in an open empty beaker,
again for 5min. This cycle was repeated 3 times for each mouse,
and then the mouse was transferred to its home cage and killed
1 h later for immunohistological analysis.
Intracranial Local Field Potential (LFP)
Recordings in the Olfactory Bulb
Stereotrodes were manufactured from 50µm thick, isolated
tungsten wire glued together with a fast drying adhesive (Roti
Coll 1, Carl Roth GmbH). Mice were prepared for surgery
as described for rAAV injections, but continuous isoflurane
anesthesia (2.5–3%) instead of Ketamine/Xylazine was used
during the whole surgery. The same stereotactic coordinates as
for the rAAV injections into the OB were used. The tungsten
electrodes were carefully lowered into the olfactory bulb and
fixed with dental cement (Hager and Werken, Cyano Veneer).
They were then lead and fixed to a custom-made head stage
(similar to EIB-16, Neuralynx) that held the connector necessary
for recordings (Omnetics Connector Corp, A79042-001). A bare
metal screw inserted over the cerebellum acted as combined
reference and ground electrode for the pre-amplifier. The whole
assembly was held in place with dental cement. The skin was
sutured where necessary. Directly after the surgery and 12/24 h
afterwards, mice were i.p. injected with 5mg/kg carprofen
(Rimadyl, Pfizer) as post-surgical analgesic (Adamson et al.,
2010). Mice were given 1 week for recovery. For intracranial
LFP recordings, a 16 channel pre-amplifier board (RHA 2116,
Intan technologies) was connected to the head stage to which
all 4 electrodes (2 stereotrodes) were connected. Pre-amplified
signals were digitized on a laptop at 25 kHz (RHA2000-EVAL
USB interface board, Intan Technologies) and saved for oﬄine
analysis without prior filtering. In every session, 10min periods
were sampled two times while mice were exploring an open
field covered with wood shavings. Videos of their behavior
were recorded from the top and analyzed oﬄine (Webcam,
Logitech, 640 × 480 pixels) by tracing the position of the
animals with routines written in Matlab (Mathworks), which
allowed to extract the total path length covered (Supplementary
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Figure 5B). After recording, animals were deeply anesthetized
with ketamine/xylazine, and electrical lesions were induced twice
(20µA, 10 s) for each single tungsten wire separately to clearly
mark electrode positions.
Offline Analysis of LFP Recordings
The raw LFP signal was analyzed oﬄine via custom Matlab
(Mathworks) routines. Briefly, the power spectra of every 10min
recording were extracted via a power spectral density estimate
(Matlab: “pwelch,” 4 s Hamming window, 50% overlap). A
linear fit was then subtracted from the power spectra (Matlab:
“detrend”), and the gamma peak frequency was found in between
50 and 90Hz. No further down sampling or other corrective
routines were employed. Signals from the left and right side of
the OB were interpreted as independent samples, and signals
from both electrodes of the stereotrode on one side were
averaged. Since effects on gamma peak frequency could differ
in between both halves of the bulb, depending on the spread
of virus expression and the exact position of the electrodes,
signals from the left and the right side were sorted for their
difference to the baseline gamma peak frequency 0.5 days after
IVM injection in both GlyRα1
AG expressing and Sham (PBS)
injected mice (Supplementary Figure 5 “Sorted: weak” and
“Sorted: strong”). For the insets in Figure 4C, spectral density
estimates were smoothed in Adobe Illustrator 17.0.0 (Object >
Path> Simplify).
Statistical Analysis
All statistics except the hippocampal slice electrophysiology
experiments (Figures 1B,C; Supplementary Figure 2, Wilcoxon
FIGURE 1 | GlyRα1
AG expression in transduced hippocampal primary neurons and acute slices of virus injected mice. (A) Top: Rat hippocampal primary
neurons infected with rAAV-syn-GlyRα1
AG-2A-Venus, rAAV-syn-Venus, and uninfected control; left column: Venus fluorescence amplified with an anti-GFP
immunostain (αGFP, green); right column anti-Beta3Tubulin (αβ3Tub, red). The rAAV-syn-GlyRα1
AG-2A-Venus infected cells show regular morphology and branching
compared to rAAV-syn-Venus infected and uninfected cells; nuclei stained with DAPI (blue); scale bar 125µm. Bottom: Cut outs of αGlyRα, αGFP and αGAPDH
immunoblots of primary neuron cell extracts infected with rAAV-syn-GlyRα1
AG-2A-Venus (GlyRα1
AG), rAAV-syn-Venus (Venus), and uninfected cells. Please note that
for αGFP blots the protein amount of rAAV-syn-Venus infected cell extracts loaded was 1µg as compared to 10µg for all other lanes shown. The full version of the
immunoblot is presented in Supplementary Figure 1. (B) Patch clamp recordings from acute brain slices of mice injected with either rAAV-syn-GlyRα1
AG-2A-Venus or
rAAV-syn-Venus (control) into the hippocampus. IVM application failed to trigger any detectable current in CA3 pyramidal cells in slices from control animals (black
trace), but activated a strong outward chloride current in Venus positive cells in slices from rAAV-syn-GlyRα1
AG-2A-Venus injected animals (red trace); box plots (right)
show cumulative data from n = 5 cells each (median, 25th/75th percentile); *p < 0.05 (C) IVM bath application had no effect on the AP frequency or the membrane
potential of control neurons (representative black trace) but lead to a strong decrease in AP frequency and membrane potential in GlyRα1
AG expressing CA3
pyramidal cells (representative red trace); box plots on the right summarize data from all recorded neurons (median, 25th/75th percentile); *p < 0.05. The open and
filled circles represent AP frequency and membrane potential in individual experiments before and after IVM application (n = 6, except membrane potential of controls
with n = 5), respectively.
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Rank Sum Test) were calculated in GraphPad Prism. Non-
parametric test statistics were used where normal distribution of
analysis results could not be proven. The level of significance was
set at p < 0.05.
RESULTS
Viral Transduction of GlyRα1
AG Leads to
Robust Expression in Primary Neurons
The efficiency of rAAV-syn-GlyRα1
AG-2A-Venus, which encodes
GlyRα1
AG linked to the fluorescent reporter protein Venus via
the T2A peptide bridge (Tang et al., 2009; Supplementary Figure
1, top), was tested in hippocampal primary neurons. Two weeks
after rAAV infection, virus-infected cells could be visualized by
enhanced Venus fluorescence (Figure 1A, top; Supplementary
Figure 1A, bottom, αGFP), and expression of GlyRα1
AG was
confirmed by staining with αGlyRα (Supplementary Figure
1A, bottom, αGlyRα). GlyRα1
AG-2A-Venus expressing cells
showed regular morphology, and αβ3Tubulin staining did not
reveal any difference in neurite growth between rAAV-syn-
GlyRα1
AG-2A-Venus, rAAV-syn-Venus infected and uninfected
primary neurons (Figure 1A). Venus fluorescence was more
intense in rAAV-syn-Venus than in rAAV-syn-GlyRα1
AG-2A-
Venus infected neurons, and immunoblots showed that Venus
protein expression in the rAAV-syn-Venus infected neurons was
at least 10 times stronger than in cells infected with rAAV-syn-
GlyRα1
AG-2A-Venus (Figure 1A, bottom; full membrane shown
in Supplementary Figure 1B). The presence of immunoreactive
GlyRα was only detectable in extracts of rAAV-syn-GlyRα1
AG-
2A-Venus infected neurons (Figure 1A) at a slightly higher
apparent molecular weight than GlyRα1
AG (48 kDa) due to
the adherent C-terminal 2A peptide (Supplementary Figure 1);
notably, no 2A-fusion proteins were detectable (Supplementary
Figure 1B), indicating that the lower expression of rAAV-
syn-GlyRα1
AG-2A-Venus is not due to incomplete ribosomal
skipping at the T2A peptide bridge.
GlyRα1
AG Expression in Hippocampal
Neurons Leads to IVM Dependent
Silencing of Neuronal Activity
To test the silencing potential of virally expressed GlyRα1
AG,
we compared the activity pattern of hippocampal pyramidal
cells in acute brain slices prepared from mice that had
received unilateral hippocampal injections of either rAAV-syn-
GlyRα1
AG-2A-Venus or rAAV-syn-Venus (controls). Infected
CA3 pyramidal cells were identified by Venus fluorescence
and patched with a high chloride (30mM) cesium containing
intracellular solution. Cells were held at−70mV. After obtaining
a stable base line, 50 nM IVM was bath-applied. In slices from
control animals, IVM did not cause significant changes in the
holding current measured before (−83 [−95.5/−62.5] pA;
median [25th/75th percentile]) and after (−89.5 [−102.5/−61.5]
pA) drug application (Figure 1B; n = 5; p > 0.05). However,
in neurons of rAAV-syn-GlyRα1
AG-2A-Venus infected mice,
IVM administration resulted in a strong and significant increase
from −58.5 [−69.5/−40.5] pA to −299 [−343.5/−282.5] pA
(Figure 1B; n = 5; ∗p < 0.05). Thus, IVM activated a strong
non-desensitizing current in GlyRα1
AG expressing neurons.
In order to determine whether activation of virally expressed
GlyRα1
AG can significantly reduce neuronal excitability, we
conducted a set of experiments in which the spontaneous firing
of CA3 pyramidal cells was enhanced by both blocking GABAA-
mediated inhibition (10mM Gabazine) and elevating the
extracellular potassium concentration (6mM K+); recordings
were conducted in the current clamp mode using an intracellular
solution containing 4mM chloride. Under these conditions,
CA3 pyramidal cells were firing single action potentials (APs)
or short bursts of 2–5 APs with an average frequency of
around 0.2Hz in both control and GlyRα1
AG expressing slices.
Application of IVM did not change the firing rate (Figure 1C
top; −IVM: 0.23 [0.18/0.31] Hz, +IVM: 0.25 [0.11/0.32] Hz;
n = 6; p > 0.05) or the resting membrane potential (−IVM:−40
[−38/−44]mV, +IVM −42 [−39/−45]mV; n = 5; p > 0.05)
of CA3 pyramidal cells in rAAV-syn-Venus injected animals.
However, in GlyRα1
AG expressing cells IVM administration
led to a significant drop in firing frequency (Figure 1C bottom;
−IVM: 0.19 [0.09/0.31] Hz, +IVM: 0.02 [0/0.04] Hz; n = 6;
∗p < 0.05) and hyperpolarization (from −41 [−44/−39]mV
to −49 [−51/−48]mV; n = 6; ∗p < 0.05). Since in the
whole cell configuration the effect of IVM triggered GlyRα1
AG
activation depends on the intracellular chloride concentration,
we tried to further substantiate these results with a set of
experiments, in which APs were detected in the cell-attached
configuration. Again, the excitability of CA3 pyramidal cells was
found to increase upon the elevation of extracellular potassium
concentration and gabazine addition. On average, the firing
rates recorded in the cell-attached configuration were higher
(about 0.5Hz) as compared to those obtained in the whole-cell
mode. In slices from control animals, the application of IVM
failed to reduce firing frequencies (Supplementary Figure 2, top;
−IVM: 0.55 [0.3/0.75] Hz, +IVM: 0.63 [0.39/0.68] Hz; n = 5;
p > 0.05). In contrast, in neurons expressing GlyRα1
AG IVM
caused robust reductions of the firing rate from 0.41 [0.26/0.7]
Hz to 0.03 [0/0.065] Hz (Supplementary Figure 2, bottom; n = 5;
∗p < 0.05).
Hippocampal Expression of GlyRα1
AG
Leads to IVM Dependent Hyperactivity and
Deficits in Spatial Working Memory
Recently, it has been shown that the trial-restricted silencing
of hippocampal excitatory neurons leads to short- and long-
term memory deficits in spatial learning (Shipton et al.,
2014). Since IVM delivery activates GlyRα1
AG over several
days, we speculated that GlyRα1
AG mediated silencing
might be an excellent tool for the investigation of multi-
trial based experiments. We therefore examined whether
the activation of hippocampally expressed GlyRα1
AG by
IVM results in an impairment of spatial working memory
(SWM), which is hippocampus dependent and tested over
several days (Deacon and Rawlins, 2006). Two weeks after
bilateral hippocampal rAAV-syn-GlyRα1
AG-2A-Venus injection
(Figure 2A), GlyRα1
AG transducedmice showed regular Rotarod
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FIGURE 2 | IVM induced hyperactivity and spatial working memory impairment in mice with bilateral neuronal expression of GlyRα1
AG in the dorsal
hippocampus. (A) Left: Injection scheme, green lines and triangles indicate the coordinates used for bilateral stereotactic rAAV-syn-GlyRα1
AG-2A-Venus injections
into the dorsal hippocampus of mice (DG, dentate gyrus; CA1 and CA3, cornu ammonis 1 and 3). Right: Time line of the experiment. (B) Left: Representative trace
diagrams in an open field of one virus uninjected control and one GlyRα1
AG transduced mouse before (−0.5 d) and after (+0.5 d) IVM exposure. Right: GlyRα1
AG
transduced mice showed a hyperactive phenotype 0.5 days after the i.p. injection of IVM; GlyRα1
AG n = 6, Uninjected n = 6; data shown as means ± SEM;
*p < 0.05. (C) Left: The two phases of the T-Maze rewarded alternation task: One arm is randomly blocked in the first trial (Forced sample trial) and re-opened in the
second trial (Free choice trial); alternations in the free choice trial are counted as correct, while re-entries into the same arm as entered in the forced sample trial are
counted as error. Right: 0.5–3.5 days after IVM injection, GlyRα1
AG expressing mice performed worse than virus uninjected control mice in the rewarded alternation
task; GlyRα1
AG n = 6, Uninjected n = 5; data shown as means ± SEM; box plot on the right shows cumulative data over all days and trials (median, 25th/75th
percentile, *p < 0.05). (D) Left: Representative image of a coronal brain section from one rAAV-syn-GlyRα1
AG-2A-Venus injected mouse [αNeuN (red) and αGFP
(green) staining]; Venus expression is prominent in both hippocampi; scale bar: 1mm. Right: Confocal imaging (maximum intensity projections) of hippocampal
subregions in coronal brain slices from a rAAV-syn-GlyRα1
AG-2A-Venus injected mouse, immunostained for αNeuN (red), αGFAP (blue), and αGFP (green); note
colocalization of NeuN and GFP fluorescences; scale bar: 20µm.
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performance compared to virus uninjected control mice, and
we found no differences between groups before or 0.5 days after
the injection of 2.5mg/kg IVM in a novel object exploration test
(Supplementary Figures 3A–C, GlyRα1
AG n = 6, uninjected
n = 6). However, 0.5 days after the delivery of IVM, GlyRα1
AG
expressing mice showed higher activity levels (total path length)
during 10min of free exploration in an open field (Figure 2B,
GlyRα1
AG n = 6, uninjected n = 6; ∗p = 0.028, Paired t-test,
two-tailed) and compared to uninjected mice after IVM delivery
(Figure 2B, GlyRα1
AG n = 6, uninjected n = 6; ∗p = 0.026,
Mann Whitney test). This finding is in line with other studies,
which demonstrated that animals become hyperactive after
lesions to the dorsal or ventral hippocampus (Douglas and
Isaacson, 1964; Nadel, 1968).
Mice were then given 2 weeks to recover from the first
IVM injections before SWM was analyzed in the food rewarded
version of the T-Maze task (Deacon and Rawlins, 2006). For
this experiment, mice were first starved to <90% of their initial
body weight (Supplementary Figure 3D). In the T-maze test, the
starved mice are initially forced by a physical block to enter
either the right or left arm of the maze to receive a food reward
(forced sample trial). In the following free choice trial, both arms
are open but only the previously unvisited arm is rewarded.
During the free choice trial, an entry in the previously blocked
arm is counted as an error (Figure 2C, left). All mice were
injected once with 2.5mg/kg IVM, and 0.5 days later the first
block of eight trials was performed. As shown in Figure 2C,
right, in contrast to virus uninjected mice, GlyRα1
AG transduced
animals did not show any improvement during four subsequent
test blocks (Figure 2C, GlyRα1
AG n = 6, uninjected n = 5;
∗p = 0.0181, performance over all days, Mann Whitney
test), but still performed significantly better than chance level
(One sample t-test to a theoretical mean of 50%: GlyRα1
AG:
∗p = 0.0019, uninjected: ∗p = 0.0089). This is consistent with
IVM injection causing a mild SWM impairment in GlyRα1
AG
expressing mice. In all rAAV injected animals, a wide-spread
expression of the fluorescent reporter was observed in both
dorsal hippocampal formations (Figure 2D). Furthermore, in
a neuronal (αNeuN) and glial [glial fibrillary acidic protein
(αGFAP)] immunostain of the hippocampus, the rAAV injected
animals showed neuron-specific expression of GlyRα1
AG and no
signs of scar tissue formation (Figure 2D).
Together these results show that the bilateral IVM mediated
activation of GlyRα1
AG in the hippocampus of mice leads to
hyperactivity and deficits in a SWM paradigm 0.5 days after drug
delivery.
Unilateral Striatal Expression of GlyRα1
AG
Leads to an IVM Dependent Rotational
Phenotype
Next, we monitored the rotation behavior in mice with unilateral
striatal GlyRα1
AG expression. This paradigm allows for the
robust behavioral readout of striatal lesions upon induction with
amphetamine (AMP) (Mandel and Randall, 1985) and can be
used to demonstrate the reversibility of IVM mediated silencing
(Lerchner et al., 2007; Hu et al., 2014). For this test, we employed
seven mice that received unilateral striatal injections of rAAV-
syn-GlyRα1
AG-2A-Venus and six mock-injected mice as controls
(rAAV-syn-GlyRα1-2A-Venus, n = 3, and rAAV-syn-Venus,
n = 3) (Figures 3A,B). Two weeks post injection, all animals
were tested for rotational bias in a small, round kitchen bowl,
which makes the quantification of subtle turning biases feasible
(Barber et al., 1973; Jerussi, 1982) (see Section Materials and
Methods). In total, 141 videos of 45min length were analyzed.
To facilitate the analysis of rotational biases, an algorithm was
developed which automatically extracts the body angle for every
frame in the recorded video (Figure 3C; Supplementary Movie
1). This way, left and right turns could be quantified reliably over
time, which then allowed calculating a turning bias (turns to one
side/all turns) for every trial. A baseline bias that was determined
from the trial prior to IVM injection was subtracted for each
mouse. As shown in Figure 3D (“BaseVar”), the overall variability
in between trials for controls without preceding IVM injection
was 10.4 ± 1.43% (Mean ± SEM, 43 videos of 6 control mice).
The first test trial was performed 0.5 days after drug injection,
since it is known that IVM reaches its peak behavioral effect after
this time (Lerchner et al., 2007) and our own preliminary results
had confirmed this observation (data not shown). In the first set
of experiments (“First IVM”), mice were injected with 3.5mg/kg
AMP 10min before the rotation behavior was recorded.
As demonstrated in Figure 3D (“First IVM”), 0.5 days after
the injection of 2.5mg/kg IVM, GlyRα1
AG transduced mice
showed a strong change in rotational bias (24.79 ± 3.02%, Mean
± SEM, n = 7), and the difference between GlyRα1
AG and
control mice reached high statistical significance (∗∗p = 0.0012,
MannWhitney test). Control mice also showed rotational biases,
however only within baseline variability (3.96 ± 1.68%, Mean
± SEM, n = 6). Mice were re-tested on subsequent days (see
representative trace diagram of one GlyRα1
AG expressing mouse
in Figure 3E), and the complete time course of the rotational
bias is shown in Figure 3E on the right. Interestingly, the IVM
elicited phenotype was reversible over the following days, such
that the difference between GlyRα1
AG expressing and control
mice (Controls + IVM) was still significant after 3 days (∗p =
0.012, Mann Whitney test), but dropped below significance on
day 8 (p = 0.057, Mann Whitney test). It declined further
until the last time point examined, i.e., 45 days after the first
IVM injection. Some mice were killed for analysis after the
first IVM injections, and others were re-injected with IVM at
a slightly lower concentration (1.5mg/kg) 9 days afterwards.
The testing in this second round of injections was performed
without previous AMP injection (Second IVM; Figure 3E, right),
since we hypothesized that our analysis method is sensitive
enough to uncover a rotational bias even without AMP stressor.
Indeed the effect observed after the first IVM injections could
be re-induced with this second IVM injection at a lower dose
and without AMP stimulation, reaching significance after 1
day (∗p = 0.017, Mann Whitney test, GlyRα1
AG n = 5)
and 2 days (∗p = 0.017, Mann Whitney test), although a
clear trend was already visible at 0.5 days post injection. The
significant difference to control mice was lost after 4 days
(p = 0.213, Mann Whitney test). Post-mortem analysis revealed
that the expression of Venus was high in the injected brain
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FIGURE 3 | Unilateral expression of GlyRα
1
AG in the striatum of mice leads to a rotational phenotype after intraperitoneal IVM injection. (A) Time line of
the experiment (AMP, amphetamine; IVM, ivermectin); injection time points of IVM are shown as arrows. (B) Injection sites; green line indicates path of injection
cannula for unilateral striatal rAAV-syn-GlyRα1
AG-2A-Venus and mock control (rAAV-syn-GlyRα1-2A-Venus and rAAV-syn-Venus) injections. Subregions depicted:
CPu, caudate putamen; LGP, lateral globus pallidus; IC, internal capsule. (C) Camera picture and overlay showing the automatic extraction of three points on the
mouse body (red dots) used to trace the rotation angle; tail point is marked in blue. (D) The baseline variability (BaseVar) of the rotational bias was quantified for all
control mice on trials without preceding IVM injection; the i.p. injection of IVM led to a strong increase in rotational bias in all GlyRα1
AG expressing mice 0.5 days after
IVM exposure as compared to IVM treated, mock injected control animals; open circles indicate group averages (1Rotation: Difference to baseline bias). (E) Left:
Example trace diagrams of a mouse injected with rAAV-syn-GlyRα1
AG-2A-Venus in the left hemisphere (45min per trace), color coded for left (green) and right (red)
turns; 0.5 days after IVM injection a strong bias to the right was found, which reversed after 6 days. Right: Time course of rotational bias after the first (2.5mg/kg) and
second (1.5mg/kg) IVM injections in GlyRα1
AG expressing mice; first bar on the left (black) shows all mock injected control mice 0.5 days after IVM injection
(Continued)
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FIGURE 3 | Continued
(Controls + IVM, pooled first and second IVM injection); stars on top of bars indicate statistical significance vs. Controls + IVM (first bar on the left); 3.5mg/kg AMP
was injected i.p. 10min before the recording started (First IVM). First IVM: GlyRα1
AG n = 7, Control n = 6; Second IVM: GlyRα1
AG n = 5; Control n = 5; data are
shown as means ± SEM; *p < 0.05, **p < 0.01, ***p < 0.001. (F) Left: Representative image of a coronal brain section of a rAAV-syn-GlyRα1
AG-2A-Venus injected
mouse, immunostained for Venus (αGFP, green) and counterstained with DAPI (blue); scale bar 1mm. Right: Maximum intensity projections of confocal microscopy
images acquired in a brain slice in the injected region (LGP), immunostained for Venus (αGFP, green) and GlyRα1
AG (αGlyRα, red), counterstained with DAPI (blue).
Note GlyRα staining surrounding Venus expressing neurons; white arrows indicate putative uninfected neurons; scale bar: 40µm.
region (Figure 3F left, see complete overview in (Supplementary
Figure 4A), although targeting patterns varied between individual
mice (Supplementary Figure 4C). Double immunolabeling and
confocal imaging confirmed that cells, which expressed the
fluorescent reporter, also contained GlyRα1
AG (Figure 3F, right).
It also showed that the infection of injected regions was highly
effective, since only a few cells (putative neurons) did not
show detectable GlyRα1
AG or Venus fluorescence. Immunoblot
analysis of tissue samples from ipsi- and contralateral striatal
regions revealed a clear ipsilateral over-expression of GlyRα1
AG
(Supplementary Figure 4B).
Together these results indicate that IVM had a reversible and
re-inducible effect on mice expressing GlyRα1
AG in one of the
striata. The rotational bias was highest between 0.5 and 1 days
after IVM i.p. injection and returned to baseline in between
4 days (1.5mg/kg IVM, −AMP) and 8 days (2.5mg/kg IVM,
+AMP).
GlyRα1
AG Mediated Silencing of Olfactory
Bulb Neurons Induces a Slowing of
Gamma Oscillations, a Decrease in Odor
Induced c-Fos Expression, and
Impairments in Odor Discrimination
The consequences of GlyRα1
AG inhibition on neuronal network
function were examined in the olfactory bulb (OB) of awake
and freely moving mice. It has been shown that enhanced
inhibition can lead to a decrease in oscillation frequency in
the gamma range (40–100Hz) in local OB networks (Bathellier
et al., 2006). Comparable effects have also been observed in
other brain regions after the injection of psychoactive drugs
and upon direct pharmacological modulation of GABAARs
(Whittington et al., 2000; Scheffzuk et al., 2013). By infecting OB
neurons with our viral construct, we investigated whether OB
fast oscillations can be modulated by the IVM induced inhibition
of neurons expressing GlyRα1
AG. We also wondered whether
evoked alterations in OB network activity could be correlated
with the performance in odor discrimination, which critically
depends on the interplay of mitral/tufted cells and granule cells
(Abraham et al., 2010).
For the analysis of local field potentials (LFPs), stereotrodes
were implanted on both sides of the OB in mice that had been
bilaterally injected with either rAAV-syn-GlyRα1
AG-2A-Venus
or PBS (GlyRα1
AG n = 4, sham n = 4; Figure 4A, left).
The implantations were targeted to the granule cell network,
close to the mitral/tufted cell layer (Supplementary Figure 5A,
left). After 1 week of recovery, stable recordings of intracranial
LFPs were obtained over many days during the exploration of
an open arena (Supplementary Figure 5A, right). Mice in both
groups were injected with 2.5mg/kg IVM 0.5 days prior to the
first recording, and recurrent recordings were obtained over the
following 7 days (Figure 4A, right). An example trace of the raw
signal collected at one electrode can be seen in Figure 4B. As
demonstrated in Figure 4C for one sham and one GlyRα1
AG
expressing mouse, gamma peak frequencies stayed remarkably
stable over all test days in the sham injected mouse, but shifted
to lower frequencies 0.5–3 days after the injection of IVM in
the GlyRα1
AG expressing mouse; all time points measured are
shown in Figure 4D. Baseline gamma peak frequencies ranged
from 62.1 to 77.6Hz in sham and 65.3 to 81.1Hz in GlyRα1
AG
expressing mice (Figure 4D left, p = 0.33, Mann Whitney
test). A decrease in gamma peak frequency was detected in
LFP subsets sorted for either weak or strong responses to
IVM in the rAAV-syn-GlyRα1
AG-2A-Venus, but not the sham
injected, mice (Figure 4D, right; Supplementary Figures 5C,D).
Interestingly, the gamma peak frequency shifted back to its
original values in IVM injected, GlyRα1
AG expressing mice
within 7 days. Moreover, this gamma frequency shift could
be re-induced with a second IVM injection and evolved over
the same time course as observed after the first IVM exposure
(Figure 4D, right; “Second IVM,” GlyRα1
AG n = 3, Sham n =
2; ∗p < 0.05; ∗∗p < 0.01, ∗∗∗p < 0.001, Mann Whitney
test). Notably, a comparable gamma peak frequency shift was
observed in 3 control mice after the injection of diazepam
(4mg/kg), a positive allosteric modulator of GABAARs, which
produced strong sedation (Supplementary Figure 5E). However,
there were no differences in mobility seen after the injection of
IVM between GlyRα1
AG and sham injectedmice (Supplementary
Figure 5B). Post-mortem analysis revealed a heterogeneous
expression of Venus at the OB injection sites, spanning part of
the granule cell network and the adjacent mitral/tufted cell layer
(Figure 4E, left). This suggests that GlyRα1
AG mediated silencing
was only effective in a subpopulation of neurons in the OB.
GlyRα immunostaining confirmed the strong over-expression of
GlyRα1
AG in Venus expressing cells (Figure 4E, right). Together
these results disclose a specific, reversible and re-inducible effect
of IVM on gamma oscillations in the OB of GlyRα1
AG expressing
mice that was pronounced between 0.5 and 3 days after IVM
delivery and reversed back to baseline within 7 days.
In order to visualize the efficiency of IVMmediated inhibition
in GlyRα1
AG expressing mice at the cellular level, we looked at
odor induced c-Fos expression in the OB of a new cohort of mice
with unilateral GlyRα1
AG expression (Figure 5A). Two weeks
after recovery from virus injection, a single episode of strong
odor exposure (see Section Materials and Methods) enhanced c-
Fos expression in the ipsi- and contralateral bulbi of GlyRα1
AG
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FIGURE 4 | IVM induced shifts toward slower gamma oscillations in the olfactory bulb of mice expressing GlyRα
1
AG. (A) Left: Injection scheme; green
lines indicate the path of the injection cannula for bilateral stereotactic rAAV-syn-GlyRα1
AG-2A-Venus and sham (PBS) injections, and blue lines symbolize the position
(Continued)
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FIGURE 4 | Continued
of the recording electrodes in the OB. Right: Time line of the experiment. Local field potentials (LFPs) were analyzed twice for 10min in freely moving mice in an open
arena on the days indicated. (B) Example raw signal of an intracranial LFP recording. Left: Fast oscillations overlying a slower rhythm are clearly visible. Right:
Magnification of the box shown on the left shows fast oscillations in the gamma range. (C) Frequency analysis of LFPs (4–200Hz) for one sham (left) and one
GlyRα1
AG expressing mouse (right) over 10min recordings; colors indicate recordings on different days over the time course of 1 week; vertical dashed line at 70Hz is
shown for reference. Inset: smoothed frequency analysis in the 40–100Hz range. (D) Left: Baseline gamma peak frequencies (pooled first and second IVM injection);
ns, not significant (p > 0.05); median, 25th/75th percentile. Right: Relative gamma peak frequencies normalized to baseline during 1 week after IVM; a substantial
shift in the relative gamma peak frequency was observable 0.5, 1.5, and 3 days after IVM treatment in the OBs of rAAV-syn-GlyRα1
AG-2A-Venus but not sham
injected mice. First IVM: GlyRα1
AG n = 4, sham n = 4 (1.5d: GlyRα1
AG n = 3, sham n = 2); second IVM: GlyRα1
AG n = 3, sham n = 2. Data shown as mean ±
SEM; *p < 0.05; **p < 0.01; ***p < 0.001. (E) Left: Stereotactic injection of rAAV-syn-GlyRα1
AG-2A-Venus into the OB yielded broad expression of Venus (αGFP,
green) at the injection site; counterstained for DAPI (blue); scale bar: 250µm. Right: Confocal imaging revealed over-expression of GlyRα1
AG (αGlyRα, red) in Venus
(αGFP, green) positive neurons; scale bar: 40µm.
expressing mice, which had received either PBS (“−IVM”) or
2.5mg/kg IVM (“+IVM”) i.p. injections 1 day before the odor
challenge (Supplementary Figure 6). However, closer inspection
of the OB sections from IVM injected mice revealed weaker c-
Fos immunostaining in those OB regions that exhibited strong
expression of GlyRα1
AG-2A-Venus (Supplementary Figure 6).
Analysis of confocal images revealed a significantly lower number
of GlyRα1
AG-2A-Venus/c-Fos co-expressing cells after IVM as
compared to PBS injection (Figure 5B, ∗p = 0.0438, unpaired
t-test,+IVM n = 3,−IVM n = 2). Thus, IVM induced silencing
occurred specifically in OB neurons with high GlyRα1
AG levels
and did not uniformly affect GlyRα1
AG expressing neuronal
networks.
To monitor odor recognition and discrimination, we trained
another cohort of 5 mice 2 weeks after bilateral OB injection
of rAAV-syn-GlyRα1
AG-2A-Venus in an olfactory discrimination
task (Mihalick et al., 2000) (Figures 6A,B; Supplementary Movie
2). All five mice reached the threshold criterion for correct
odor discrimination (seven correct out of eight trials over 2
consecutive days) within time windows comparable to those
seen with four sham (PBS) injected mice (p = 0.81, Mann
Whitney test), indicating that virus injection and GlyRα1
AG
expression in the OB did not interfere with odor recognition
and discrimination (Figure 6C, left). However, when all mice
were injected with 2.5mg/kg IVM i.p. after they had reached the
threshold, only GlyRα1
AG expressing animals showed a dramatic
drop in odor discrimination performance 0.5–1.5 days later
(Figure 6C, right, ∗p = 0.024, Mann Whitney test). In line with
our other results, this performance deficit was only transient and
recovered fully after 7 days (p = 0.132, Mann Whitney test).
Alterations in odor sensitivity and/or motivational aspects had
no impact on the performance of mice in this discrimination
task, since there were no significant differences found in decision
times in between groups (Supplementary Figure 7A). Moreover,
mice in both groups performed a pellet seeking task within
comparable time spans before and 1.5 days after IVM injection
(Supplementary Figure 7B). This suggests that the silencing of
OB neurons specifically impaired performance within the odor
discrimination task while leaving odor sensitivity unaffected.
DISCUSSION
In this study, we demonstrate that long-term reversible and
re-inducible neuronal silencing via the IVM gated GlyRα1
AG
(Lynagh and Lynch, 2010) can be used as an efficient tool
for the investigation of neuronal networks and behavior. In
acute hippocampal slices prepared from rAAV-syn-GlyRα1
AG-
2A-Venus injected mice, but not in slices from rAAV-syn-
Venus injected mice, we could record an IVM induced
hyperpolarization indicative of the functional expression of
GlyRα1
AG in neurons of adult mice. This IVM induced
hyperpolarization was accompanied by a strong decrease in AP
frequency.
Intraperitoneal injection of 2.5mg/kg IVM had no detectable
effects on control mice but induced representative behavioral
impairments in mice, which had received rAAV-syn-GlyRα1
AG-
2A-Venus injections into the striatum, hippocampus or olfactory
bulb. In our experiments, the effects of GlyRα1
AG activation were
detectable 12 h after IVM i.p. injection peaked between 24 and
36 h, and returned to baseline within 1 week; this is consistent
with the time courses of IVM effects observed in virus-injected
and transgenic animals (Lerchner et al., 2007; Hu et al., 2014).
Although the IVM concentrations used in our study were lower
than the ones employed in previous in vivo studies with IVM
activated chloride channels (5mg/kg) (Lerchner et al., 2007; Hu
et al., 2014), we were able to generate effects of comparable
size (Figure 3E, Second IVM: 1.5mg/kg). This could be due to
higher GlyRα1
AG expression levels achieved by delivery through
rAAVs and synapsin promotor driven transcription. Importantly,
the lower IVM dose used here should help to diminish possible
IVM off-target effects on endogenous GABAARs and GlyRs
(Adelsberger et al., 2000; Dawson et al., 2000; Shan et al.,
2001). Despite the reduced IVM concentration, the behavioral
effects of IVM induced GlyRα1
AG silencing reversed only after
4–8 days. Since the binding of IVM to GlyRs is irreversible
(Shan et al., 2001), probably due to membrane integration of
the lipophilic drug (Zemkova et al., 2014), the limiting factor
for the recovery from silencing likely is a combination of rate-
limited IVM clearance from the brain (Crichlow et al., 1986)
and the replacement of GlyRα1
AG by newly translated receptors
over time. We hypothesize that a further reduction of IVM
concentrations might be possible which should accelerate the
clearance of IVM liganded GlyRα1
AG and thereby shorten the
overall time course of IVM dependent neuronal silencing. A
shorter time window of GlyRα1
AG mediated inhibition should
help to reduce the risk of homeostatic plasticity (Turrigiano,
1999) and permanent network changes that may occur when
stimulatory inputs are removed (Margolis et al., 2012).
After recovery, neuronal silencing could be re-induced by a
second IVM injection, as shown in the rotational assay (Striatum,
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FIGURE 5 | IVM induced GlyRα1
AG activation lead to a decrease in odor induced c-Fos expression in the olfactory bulb. (A) Left: Scheme of unilateral
stereotactic OB injection of rAAV-syn-GlyRα1
AG-2A-Venus. Black squares indicate approximate size and position of fields shown in (B). ML, mitral/tufted cell layer;
GL, glomerular layer; GR, granule cell layer. Right: Time line of the experiment; the c-Fos induction protocol used 1 day after IVM injection is shown on the right. (B)
Left: Fields of 150× 150µm were evaluated for c-Fos (αc-Fos, red) and Venus (αGFP, green) expression. Without IVM injection (−IVM), the number of c-Fos
immunoreactive cells was comparable on contra- and ipsilateral sides; after the injection of IVM (+IVM), the number of c-Fos immunoreactive cells and the number of
GFP and c-Fos double labeled cells decreased steeply on the ipsilateral side (arrow tips: c-Fos only labeled cells, whole arrows: GFP/c-Fos double positive cells);
scale bar: 30µm. Right: Quantification of GFP and c-Fos positive cells (top row) and GFP/c-Fos double positive cells (bottom row), numbers per 150× 150µm;
horizontal line indicates mean; GlyRα1
AG +IVM, n = 3; GlyRα1
AG −IVM, n = 2; *p < 0.05.
Figure 3) and by recording gamma oscillations (OB, Figure 4),
suggesting that GlyRα1
AG silenced neuronal networks do not
undergo permanent changes. Importantly, we did not observe
any obvious toxic effects of GlyRα1
AG expression on transduced
neurons, and the activation of GlyRα1
AG with IVM did not lead
to observable cell death or reactive gliosis.
We found that the induction of the immediate early gene
c-Fos, a marker of neuronal activity (Clayton, 2000), was
suppressed in GlyRα1
AG expressing olfactory bulb neurons
after injection of IVM, and a quantification at the cellular scale
revealed that this suppression was restricted to GlyRα1
AG
transduced neurons and not a broader regional effect.
This observation further underscores the specificity of our
chemogenetic silencing approach. It also indicates that the
silencing of a heterogeneous group of neurons was sufficient
to promote a rotational phenotype, the observed SWM deficits
and impairments in the odor discrimination task. Currently,
we cannot discern whether the silencing of interneurons or
excitatory neurons contributed to the observed phenotypes,
since rAAV-syn-GlyRα1
AG-2A-Venus is expressed in all classes
of neurons. Nevertheless, the simultaneous silencing of principal
and interneurons induced by IVM can lead to a transient
imbalance in excitatory/inhibitory network drive, as disclosed
by the shift in gamma oscillations seen in the GlyRα1
AG
silenced OBs. Clearly, further experiments with cell-type specific
expression of GlyRα1
AG are needed to dissect the specific
network mechanism underlying these slowed gamma oscillations
in the OB. We speculate that increased inhibition in a neuronal
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FIGURE 6 | IVM induced GlyRα1
AG activation in the olfactory bulb lead to a deficit in odor discrimination. (A) Left: Scheme of bilateral stereotactic
rAAV-syn-GlyRα1
AG-2A-Venus and sham (PBS) injections into the OB. Right: Time line of the experiment. Small black arrows indicate days on which olfactory
discrimination testing was performed. (B) Picture of the apparatus used in the discrimination test; the lids (blue) were scented with two odors of which only one was
rewarded; both lids could be quickly removed from the apparatus if mice started to dig on the side with the wrong odor. (C) Left: The number of days in the acquisition
phase required to reach the threshold criterion did not differ significantly in between groups (median, 25th/75th percentile, p > 0.05). Middle: 0.5–1.5 days after IVM
injection, GlyRα1
AG expressing mice performed worse than on the 3 days prior to injection and compared to sham injected mice; mice recovered from this deficit 8
days after IVM injection. Right: Comparison of pairs of test days, each: -2 d and -1 d prior to, 0.5 d and 1.5 d after, and +8 d and +9 d after, IVM injection; GlyRα1
AG
n = 5, Sham n = 4. Data shown as means ± SEM; *p < 0.05, **p < 0.01, ***p < 0.001.
network as well as a lack thereof can lead to very similar
impairments, as exemplified by the similar working memory
impairments elicited through both optogenetic silencing of CA3
excitatory neurons (Shipton et al., 2014) and the lack of AMPAR
subunits on parvalbumin-positive interneurons (Fuchs et al.,
2007).
Neuronal silencing through the activation of virally
transduced GlyRα1
AG as described here should be feasible
in a wide range of experimental setups and model organisms
because of the ease of delivery through rAAVs. Especially the
ability to non-invasively modulate the activity of distributed
neuronal networks in the brain over subsequent days makes
GlyRα1
AG an attractive tool for behavioral research. While
the precision of GlyRα1
AG mediated silencing in the temporal
domain cannot be compared to current optogenetic methods,
it can be considered superior in the spatial domain. Current
optogenetic methods are not practical for the simultaneous
control of extended brain regions and distributed neuronal
ensembles, since sufficient illumination is required to activate
them. This in turn requires the implantation of light conducting
fibers, which increases the invasiveness of the experiment. As
shown rather recently, transient manipulations as performed
with optogenetic or fast pharmacological silencers might
overestimate the steady-state function of a silenced neuronal
network by evoking acute off-target effects in connected brain
regions (Otchy et al., 2015). Thus, GlyRα1
AG mediated silencing,
which reaches its peak effect on far slower time scales, might
become an important tool for examining the function of
a silenced neuronal network beyond acute disturbances in
network homeostasis. Currently used chemogenetic silencers
(hM4Di, KORD; Armbruster et al., 2007; Vardy et al., 2015)
circumvent these problems in part, but act on faster time courses
than GlyRα1
AG and therefore require frequent re-activation if
used over the time course of hours and days (Ferguson et al.,
2013; Vardy et al., 2015; Marchant et al., 2016). While these
time courses might be desirable in some experimental setups,
the stress of i.p. injection temporally close to behavioral testing
is counterproductive for tasks involving decision making and
other cognitive tests. The long onset and slow reversal of IVM
mediated GlyRα1
AG silencing therefore represents an attractive
alternative for silencing neuronal networks in multiple learning
trials or over extended time periods.
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